Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as an ophthalmic suspension for ocular use. It treats post‑operative ocular inflammation, allergic conjunctivitis and anterior uveitis in patients requiring anti‑inflammatory therapy.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Maxidex (dexamethasone) is a corticosteroid used to manage inflammatory ocular conditions.

- Post‑operative ocular inflammation: reduces swelling and pain after eye surgery. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergens. - Anterior uveitis: suppresses intra‑ocular inflammation to preserve vision.

Adverse ocular reactions may occur with the use of Maxidex.

Common Side Effects: - Blurred vision: temporary reduction in visual clarity. - Eye irritation or burning: mild discomfort on instillation. - Increased intra‑ocular pressure: may require monitoring. - Cataract formation: potential with prolonged use.

Serious or Rare Side Effects: - Secondary ocular infection: bacterial or fungal overgrowth. - Severe allergic reaction: swelling, redness, or rash. - Glaucoma: sustained pressure elevation leading to optic nerve damage. - Retinal detachment: rare but vision‑threatening emergency.

Use Maxidex only under professional supervision and observe safety measures. - Intra‑ocular pressure monitoring: check pressure regularly during therapy. - Infection risk: avoid use in active ocular infections unless directed. - Minimum effective dose: employ the lowest dose needed for therapeutic effect. - Hypersensitivity: discontinue if allergic signs appear. - Store at room temperature: keep in the original container, protect from moisture and light.

Consider potential drug interactions when prescribing Maxidex.

Major Interactions (Avoid): - Systemic corticosteroids: additive systemic glucocorticoid effects. - Potent CYP3A4 inhibitors: may increase systemic exposure of dexamethasone. - Antiviral ophthalmic agents (e.g., ganciclovir): may reduce antiviral efficacy.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: possible additive irritation. - Antihistamine eye drops: may alter ocular absorption. - Systemic immunosuppressants: monitor for enhanced immunosuppression.